EcoR1 Capital Files Initial Ownership for First Tracks Bio
Ticker: TRAX · Form: 3 · Filed: Apr 22, 2026 · CIK: 0002091349
Sentiment: neutral
Topics: insider-filing, ownership, biotech
TL;DR
EcoR1 Capital just filed their initial ownership for First Tracks Bio. Big player entering?
AI Summary
On April 22, 2026, EcoR1 Capital, LLC filed a Form 3, an initial statement of beneficial ownership, for First Tracks Biotherapeutics, Inc. The filing indicates EcoR1 Capital, LLC's initial holdings in the company as of April 20, 2026. The mailing and business addresses for both entities are provided.
Why It Matters
This filing marks the initial public declaration of beneficial ownership by EcoR1 Capital, LLC in First Tracks Biotherapeutics, Inc., providing insight into a significant stakeholder's entry or increased stake.
Risk Assessment
Risk Level: low — A Form 3 filing is a routine disclosure of initial beneficial ownership and does not inherently indicate significant risk.
Key Players & Entities
- EcoR1 Capital, LLC (company) — Reporting entity
- First Tracks Biotherapeutics, Inc. (company) — Issuer
- 0000935836-26-000207 (filing_id) — SEC Accession Number
- 2026-04-22 (date) — Filing Date
- 2026-04-20 (date) — Period of Report
FAQ
What is the purpose of a Form 3 filing?
A Form 3 is an initial statement of beneficial ownership of securities filed by individuals or entities who become a greater than 10% owner or a director or officer of a public company.
Who is the reporting entity in this filing?
The reporting entity is EcoR1 Capital, LLC, with CIK 0001587114.
Who is the issuer of the securities?
The issuer is First Tracks Biotherapeutics, Inc., with CIK 0002091349.
When was this filing accepted by the SEC?
This filing was accepted on April 22, 2026.
What is the period of report for this filing?
The period of report is April 20, 2026.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 22, 2026 regarding First Tracks Biotherapeutics, Inc. (TRAX). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.